Cyclenium Pharma is a privately-held pharmaceutical research and development company exploiting its proprietary CMRT™ macrocyclic drug discovery technology for the discovery and development of novel small molecule therapeutic agents to address areas of unsatisfied medical need. Cyclenium is creating value through progression of programs in oncology, infectious diseases and inflammation/pain on its own or in partnership with leading academic and non-profit organizations as well as collaborations with innovative pharmaceutical and biotechnology companies seeking to modulate unique and difficult disease targets in diverse therapeutic areas.